-+ 0.00%
-+ 0.00%
-+ 0.00%

SAVARA - FDA REVIEW OF SAVARA'S MOLGRAMOSTIM BLA ONGOING; NO REVISED ACTION DATE PROVIDED

Reuters·11/20/2026 13:30:00

Please log in to view news